Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progressi... Kura Oncology Inc is a clinical-stage biopharmaceutical company, that engages in discovering and developing therapeutics for the treatment of solid tumors and blood cancers. It focuses on the development of small-molecule product candidates that target cell signalling pathways to drive the progression of various cancers. The company has a lead product candidate, Tipifarnib, which is a farnesyl transferase inhibitor, in both solid tumors and blood cancers. It is advancing KO-947, a small molecule inhibitor of extracellular-signal-regulated kinase (ERK), as a treatment for patients with pancreatic cancer, colorectal cancer, non-small cell lung cancer (NSCLC) and melanoma. Geographically operation of the group is carried through the United States. Show more
SAN DIEGO, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
– Topline data from registration-directed trial of ziftomenib in R/R NPM1-mutant AML expected in early 2025 – – Breakthrough Therapy Designation granted for ziftomenib in R/R NPM1-mutant AML – –...
– Preclinical data suggest combination of ziftomenib and imatinib has potential to resensitize patients to imatinib and induce durable responses – – Proof-of-concept study evaluating ziftomenib...
SAN DIEGO, Aug. 01, 2024 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company committed to realizing the promise of precision medicines for the...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.51 | -2.42626070409 | 21.02 | 21.4 | 19.99 | 622721 | 20.74549502 | CS |
4 | 0.22 | 1.08427796944 | 20.29 | 21.569 | 19.12 | 453624 | 20.29854855 | CS |
12 | 0 | 0 | 20.51 | 23.48 | 17.915 | 597846 | 20.25407105 | CS |
26 | -0.94 | -4.38228438228 | 21.45 | 23.48 | 16.79 | 680962 | 20.33509061 | CS |
52 | 11.7 | 132.803632236 | 8.81 | 24.17 | 7.41 | 956207 | 17.23389852 | CS |
156 | 0.13 | 0.637880274779 | 20.38 | 24.17 | 7.41 | 834070 | 15.07760712 | CS |
260 | 4.18 | 25.5970606246 | 16.33 | 43 | 6.34 | 736899 | 17.92512942 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.